VMD medicines update - October 2025 | British Equine Veterinary Association
  1. Resources
  2. Education
  3. Career support
  4. Get involved
  5. About us
BEVA Logo
  1. Resources
  2. Education
  3. Career support
  4. Get involved
  5. About us

VMD medicines update - October 2025

News Medicines
18 Nov 2025 BEVA

This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets.

Changes to authorisations most relevant to vets

The changes to authorisations most relevant to vets can be found below. Each product is listed, along with the authorisation holder, distribution category and details of which Summary of Product Characteristics (SPC) sections have been revised/changed.

Changes to the SPC, labels and leaflets may change how the medicines should be used.  Details can be found on the VMD’s Product Information Database (PID).

Due to ongoing assessments, there may be a delay between the point at which a new change is authorised and the updated SPC being available on the PID.  There may also be a delay between the point at which any SPC changes are authorised and implementation in the product literature. Unless you have been advised otherwise, the labelling instructions on the pack which is dispensed should be followed.

Food producing animals

Anesketin 100 mg/ml Solution for Injection for Dogs, Cats and Horses

Eurovet Animal Health B.V         GB and NI           POM-V

Section 4.9 of the SPC: The vials are not vacuum-sealed and do not require air to be introduced to withdraw its content.

Introducing air into the vial prior to withdrawal of its content may lead to leakage.

For more information, contact the VMD at postmaster@vmd.gov.uk